Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.82 - $9.26
Previous CloseN/A
Volume261.88K
Average Volume (3M)1.26M
Market Cap
$1.78B
Enterprise Value$1.88B
Total Cash (Recent Filing)$968.69M
Total Debt (Recent Filing)$704.92M
Price to Earnings (P/E)108.9
Beta1.08
Next Earnings
May 07, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding106,740,326
10 Day Avg. Volume689,942
30 Day Avg. Volume1,258,272
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.52
Enterprise Value/Ebitda12.28
Forecast
1Y Price Target
$6.44Price Target Upside38.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Discount Platform RecognitionGoodRx is recognized as the best discount platform for generic Rx discounts in terms of both depth and breadth.
E-commerce IntegrationBy integrating the prescription purchasing process into GoodRx’s app, consumers could purchase medications before reaching the pharmacy counter, reducing time spent at the pharmacy and increasing convenience.
Manufacturer Solutions GrowthManufacturer Solutions is likely to be GDRX's biggest growth driver with expected segment growth of approximately 20%.
Bears Say
Competitive PressureThe competitive gap between GoodRx and its rivals is narrowing, likely limiting upside to the core business.
PBM-to-Pharmacy ReimbursementCaution related to changes in the PBM-to-pharmacy reimbursement landscape that are taking place.
Pharmacy ClosuresThe recent increase in retail pharmacy closures poses a challenge to GoodRx.
---
Ownership Overview
11.18% Insiders
12.94% Mutual Funds
0.44% Other Institutional Investors
65.12% Public Companies and
Individual Investors
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $3.82 and its highest was $9.26 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $1.78B.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is May 07, 2025 which is in 4 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Feb 27, 2025. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.091 by -$0.001.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.1.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 106,740,326 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.09 in its last earnings report, missing expectations of $0.091. Following the earnings report the stock price went up 1.84%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
---
GoodRx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.44 (38.79% Upside)
$6.44 (38.79% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 60%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 919.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 2.3%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.42%
12-Months-Change
Fundamentals
Return on Equity
2.21%
Trailing 12-Months
Asset Growth
-12.63%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
---
GDRX Company Deck
---
GDRX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reveals significant growth and achievements in consumer reach, pharmacy partnerships, and financial metrics, with a few notable challenges in subscription revenue and ISP program expansion.Read More>---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$6.44
▲(38.79% Upside)
Technical Analysis
---